LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 98 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2018. The put-call ratio across all filers is 2.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $30,824,000 | -53.3% | 3,268,744 | -0.3% | 0.03% | -44.3% |
| Q3 2018 | $66,012,000 | -29.0% | 3,279,272 | +2.8% | 0.06% | -33.0% |
| Q2 2018 | $93,010,000 | -0.4% | 3,188,533 | +1.6% | 0.09% | -2.2% |
| Q1 2018 | $93,422,000 | +30.7% | 3,137,062 | +41.3% | 0.09% | +31.0% |
| Q4 2017 | $71,455,000 | +0.1% | 2,220,482 | +8.2% | 0.07% | -2.7% |
| Q3 2017 | $71,398,000 | +16.8% | 2,052,847 | -0.0% | 0.07% | +12.3% |
| Q2 2017 | $61,132,000 | +15.8% | 2,053,467 | +16.1% | 0.06% | +14.0% |
| Q1 2017 | $52,781,000 | +1068.2% | 1,768,213 | +586.1% | 0.06% | +1040.0% |
| Q4 2016 | $4,518,000 | -26.3% | 257,709 | 0.0% | 0.01% | -28.6% |
| Q3 2016 | $6,131,000 | +51.8% | 257,709 | +2.1% | 0.01% | +75.0% |
| Q2 2016 | $4,039,000 | -22.3% | 252,437 | +1.6% | 0.00% | -20.0% |
| Q1 2016 | $5,198,000 | – | 248,574 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|